Sign In
Buy BSGM
$6.10
+0 (+0%)
At Close: Dec 10, 2025
BioSig Launches Enhanced Signal Processing Capabilities for Advanced Cardiac Signal Analysis Through its Electrophysiology Platform
09:29am, Wednesday, 14'th Apr 2021
Westport, CT, April 14, 2021 (GLOBE NEWSWIRE) -- The latest release represents the most advanced software version of the PURE EPTM System, signal processing technology for treatments of irregular hear
BioSig Technologies completes enrollment in PURE EP 2.0 clinical trial
11:28am, Tuesday, 13'th Apr 2021
BioSig Technologies Inc (NASDAQ:BSGM) said it has completed enrollment in the PURE EP 2.0 clinical trial. The multi-center, prospective clinical trial was conducted at the Texas Cardiac Arrhythmia Ins
BioSig Completes Enrollment in the PURE EP 2.0 Clinical Study
09:32am, Tuesday, 13'th Apr 2021
Westport, CT, April 13, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative signal process
BioSig Invited to Join Alliance for Artificial Intelligence in Healthcare (AAIH)
09:32am, Friday, 09'th Apr 2021
Westport, CT, April 09, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative signal process
BioSig Technologies sees its PURE EP System highlighted in new feature article in EP Lab Digest
10:15am, Thursday, 08'th Apr 2021
BioSig Technologies Inc (NASDAQ:BSGM) has seen its PURE EP System featured in the new edition of leading electrophysiology trade publication, EP Lab Digest. This is the second time that the computeriz
EP Lab Digest Features Physician Experience with BioSig's Cardiac Signal Acquisition Technology
09:32am, Thursday, 08'th Apr 2021
Westport, CT, April 08, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) ("BioSig" or the "Company"), a medical technology company commercializing an innovative signal processing plat
BioSig Technologies looking to unlock the future of bioelectronic medicine
01:41pm, Tuesday, 06'th Apr 2021
Using targeted electrical signals to harness the body's natural mechanisms to diagnose and treat a range of diseases Has commercialized its first product, a biomedical signal processing platform call
BioSig Technologies, Inc. (NASDAQ:BSGM) has announced that a top-rated leading hospital system has purchased the company's PURE EP systems for multiple campuses in its national network. “We are p
BioSig lands Commercial Sales to Leading Hospital System
09:45am, Tuesday, 06'th Apr 2021
Westport, CT, April 06, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative signal process
BioSig Technologies, Inc. to Present at the 20th Annual Needham Virtual Healthcare Conference
10:00am, Monday, 05'th Apr 2021
Westport, CT, April 05, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) ("BioSig" or the "Company"), a medical technology company commercializing an innovative signal processing plat
BioSig Technologies awarded US patent claims for noise-filtering methods of signal processing technology
10:44am, Tuesday, 30'th Mar 2021
BioSig Technologies Inc (NASDAQ:BSGM) said that US Patent Office has allowed a utility patent covering its PURE EP noise-filtering technology. The medical technology firm, which specializes in commerc
BioSig Awarded U.S. Patent Claims for the Noise-Filtering Methods for its Signal Processing Technology
08:30am, Tuesday, 30'th Mar 2021
Westport, CT, March 30, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative signal process
BioSig CEO says PURE EP System is “gaining momentum” as it adds new healthcare facilities
02:53pm, Monday, 29'th Mar 2021
BioSig Technologies Inc (NASDAQ:BSGM) founder, Chairman, and CEO Kenneth L. Londoner told investors on Monday that the commercial adoption of the company's first product called the PURE EP, which meas
BioSig Issues Shareholder Letter with Corporate Update on Recent Achievements and Anticipated Milestones for 2021
09:15am, Monday, 29'th Mar 2021
Westport, CT, March 29, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing a proprietary biomedical sig
BSGM Stock Price Increases Over 5% Pre-Market: Why It Happened
07:21am, Thursday, 25'th Mar 2021
The stock price of BioSig Technologies Inc (NASDAQ: BSGM) increased by over 5% pre-market. This is why it happened.
